Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

84 results
Display

A case of syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine

Ahn HJ, Kim HW, Kim YS, Kim YO, Yoon SA, Choi JK

  • KMID: 2259061
  • Korean J Med.
  • 2010 Dec;79(6):710-713.
Paroxetine is a well-known selective serotonin reuptake inhibitor, and has been reported to be advantageous for chronic pain control. Paroxetine is increasingly used for various types of chronic pain because...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea

Singh M, Anwar Z, Sinha V, Narwal V, Mitra S, Bharti A, Mishra AK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Paroxetine-induced Hypoglycemia in Type 2 Diabetic Patient

Han S, Park HS, Lee YH, Lee BW, Kang ES, Cha BS

Selective serotonin reuptake inhibitors are commonly prescribed drugs for the treatment of depression in the patients with diabetes. Here, we report a case of paroxetineinduced severe recurrent hypoglycemia that developed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Paroxetine on the Desensitization of 5-HT(1A) and 5-HT(1B) Receptors

Park HY

No abstract available in English.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Paroxetine-Related Hyperprolactinemia

Baek DU, Cho MA, Jae YM

  • KMID: 2287387
  • Korean J Psychopharmacol.
  • 2010 Apr;21(2):99-103.
Although selective serotonin reuptake inhibitors (SSRIs) have been widely used in both psychiatry and other medicine, few cases have been reported SSRI-related hyperprolactinemia and/or galactorrhea. We experienced one case which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Hyponatremia Associated with Paroxetine: A case report

Sohn MK, Hwang SL, Song HT, Lim JH

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) widely used for depression in brain damaged patients as it is known for its few affects on cognition or psychomotor function. Major...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Provoked Bradycardia Associated with a Combination Treatment of Paroxetine and Carvedilol

Pae CU, Yang WS, Kim JJ, Lee CU, Lee SJ, Lee C, Paik IH

  • KMID: 2340838
  • J Korean Neuropsychiatr Assoc.
  • 2003 Mar;42(2):280-282.
Selective serotonin reuptake inhibitors (SSRIs) have been used for patients with depressive disorder because of their favorable side effect profiles. However, SSRIs have variable drug interactions because of the inhibitory...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy and Safety of Paroxetine on the Treatment of Premature Ejaculation

Park KS, Lee JG, Yoon JS, Kwon DD, Oh BR, Ryu SB, Park YI

  • KMID: 2172432
  • Chonnam Med J.
  • 2001 Mar;37(1):27-32.
Premature ejaculation is the most common male sexual dysfunction. Recently, paroxetine, a potent serotonin reuptake inhibitor, has been suggested to be helpful for the patients with premature ejaculation. We evaluated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Effects of Paroxetine and Amitriptyline on the Psychomotor Performancein Healthy Volunteers

Kim CY, Choi MK, Lee CH, Ahn JH, Lee C, Han OS

  • KMID: 2340402
  • J Korean Neuropsychiatr Assoc.
  • 1999 Nov;38(6):1469-1478.
OBJECTIVES: Paroxetine is known to have fewer cognitive side effects than older antidepressants such as amitriptyline. To confirm this objectively, we compared the effects of paroxetine on the psychomotor performance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Blockade of Kv1.5 by paroxetine, an antidepressant drug

Lee HM, Hahn SJ, Choi BH

Paroxetine, a selective serotonin reuptake inhibitor (SSRI), has been reported to have an effect on several ion channels including human ether-a-go-go-related gene in a SSRI-independent manner. These results suggest that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Paroxetine on Symptoms of Hwa-Byung

Min SK, Suh SY, Jon DI, Hong HJ, Park SJ, Song KJ

  • KMID: 2287401
  • Korean J Psychopharmacol.
  • 2009 Mar;20(2):90-97.
OBJECTIVE: This study consists of a single open clinical trial to evaluate the treatment effects of paroxetine on symptoms of hwa-byung, a Korean culture-related anger syndrome. METHODS: Eighty-nine patients with depressive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Selective Mutism Arising from First Language Attrition, Successfully Treated with Paroxetine-CBT Combination Treatment

Serra A, Di Mauro P, Andaloro C, Maiolino L, Pavone P, Cocuzza S

After immersion in a foreign language, speakers often have difficulty retrieving native-language words and may experience a decrease in its proficiency, this phenomenon, in the non-pathological form, is known as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Advances in the Pharmacotherapy of Generalized Anxiety Disorder

Kim CH

  • KMID: 2286869
  • Korean J Psychopharmacol.
  • 2004 Mar;15(1):9-13.
Generalized anxiety disorder (GAD), that has been introduced into psychiatric nosology in DSM-III, is characterized by chronic worry that may persist for many years. Pharmacological treatment for GAD includes benzodiazepines,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect

Park HJ, Lee ST, Shim JY, Kim B, Hwang SH, Kim SH, Park JE, Park JH, Jung SH, Ahn JY, Chu K, Kim M

BACKGROUND AND PURPOSE: Anxiety is the most important precipitating factor of migraine attacks, and more than half of migraineurs have coexisting anxiety disorders. Paroxetine, an antidepressant, is one of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Paroxetine in the Treatment of Major Depression in Patients with Hematological Malignancy

Pae CU, Lee HJ, Kim JJ, Lee CU, Lee SJ, Lee C, Paik IH

  • KMID: 1636035
  • J Korean Neuropsychiatr Assoc.
  • 2003 Jul;42(4):485-491.
OBJECTIVES: The efficacy and safety of paroxetine in the treatment of depressive disorders are well known, however its efficacy and safety for the treatment of depression in patients with cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report

Ram D, Patil S, Gowdappa B, Rajalakshmi I

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Paroxetine on a Human Ether-a-go-go-related Gene (hERG) K⁺ Channel Expressed in Xenopus Oocytes and on Cardiac Action Potential

Hong HK, Hwang S, Jo SH

K⁺ channels are key components of the primary and secondary basolateral Cl- pump systems, which are important for secretion from the salivary glands. Paroxetine is a selective serotonin reuptake inhibitor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The interaction of morphine and selective serotonin reuptake inhibitors on mechanical allodynia in rats with a spinal nerve ligation

Kwon MY, Jun IG, Kim TH, Park JY

BACKGROUND: Nerve injury may produce a tactile allodynia. However, there are few reports regarding the interaction of morphine and selective serotonin reuptake inhibitors (SSRIs) during a neuropathic pain state. Therefore,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel

Lee HM, Chai OH, Hahn SJ, Choi BH

In patients with epilepsy, depression is a common comorbidity but difficult to be treated because many antidepressants cause pro-convulsive effects. Thus, it is important to identify the risk of seizures...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of the Short-Term Treatment of Paroxetine on Psychological States in Panic Disorder

Lee SY, Kim JH, Kim YR, Kang EH, Lee DS, Yu BH

  • KMID: 2341004
  • J Korean Neuropsychiatr Assoc.
  • 2004 May;43(3):312-319.
OBJECTIVES: This study was designed to evaluate clinical effect of paroxetine treatment and to explore psychological predictors of treatment response. METHODS: Patients (n=26) who met DSM-IV criteria for panic disorder with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr